Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

The FDA has approved Telithromycin, the first Ketolide antibiotic. Ketolides are semisynthetic derivatives of the macrolide erythromycin that have activity against a wide spectrum of respiratory bacterial pathogens including multi-drug resistant <i>Streptococcus pneumoniae</i>. Telithromycin, which is a once-a-day oral tablet, is marketed by Aventis as Ketek.

Telithromycin Tablets (Ketek)